Degradation of porstaglandin F2alpha in the human pulmonary circulation.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Thorax

• Publication date

  1976-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.31.6.713PMID 1013942PMCID PMC470500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bioassay and thin-layer chromatography of prostaglandins and their pulmonary metabolites [proceedings].

  1976cited by this paper
• The influence of environmental agents on prostaglandin biosynthesis and metabolism in the lung. Inhibition of lung 15-hydroxyprostaglandin dehydrogenase by exposure of guinea pigs to 100 per cent oxygen at atmospheric pressure.

  1975cited by this paper
• Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma.

  1975cited by this paper
• Metabolism of prostaglandins A1 and E1 in man.

  1975cited by this paper
• COMPARATIVE BIOASSAY OF PROSTAGLANDIN E2 AND ITS THREE PULMONARY METABOLITES

  1975cited by this paper
• Radioimmunoassay of Prostaglandins Fα, E1 and E2 in Human Plasma

  1975cited by this paper
• Pharmacokinetic function of the pulmonary circulation.

  1974cited by this paper
• Radioimmunoassay of prostaglandin F2α in peripheral venous plasma from men and women

  1974cited by this paper
• A comparison of the effects of prostaglandin E(2) and salbutamol by intravenous infusion on the airways obstruction of patients with asthma.

  1974cited by this paper
• Radioimmunoassay of prostaglandin F-2-alpha in peripheral venous plasma from men and women.

  1974cited by this paper
• Electron microscopy of endothelial and epithelial components of the lungs: correlations of structure and function.

  1973cited by this paper
• Human blood prostaglandins: formation during clotting.

  1972cited by this paper
• Analysis of Prostaglandin F2a, and Metabolites in Blood during Constant Intravenous Infusion of Prostaglandin F2a, in the Human Female

  1972cited by this paper
• Analysis of prostaglandin F 2 and metabolites in blood during constant intravenous infusion of prostaglandin F 2 in the human female.

  1972cited by this paper
• Inactivation of Prostaglandins by the Lungs

  1970cited by this paper
• Selective Passage of Prostaglandins across the Lung

  1969cited by this paper
• The release and fate of vaso‐active hormones in the circulation

  1969cited by this paper
• Nonrespiratory Functions of Mammalian Lung

  1969cited by this paper
• Prostaglandins A1, A2 and 19‐hydroxy A1; their actions on smooth muscle and their inactivation on passage through the pulmonary and hepatic portal vascular beds

  1969cited by this paper
• Prostaglandins: Their Disappearance from and Release into the Circulation

  1967cited by this paper
• A method for measuring airway resistance in man.

  1961cited by this paper
• A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

  1957cited by this paper
• A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.

  1956cited by this paper
• A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects.

  1956cited by this paper

• Hormonal regulation of labor: a review of physiological mechanisms and diagnostic capabilities

  2025cites this paper
• Mechanism of BLIMP1/TRIM66/COX2 in human decidua participates in parturition

  2023cites this paper
• Pathogenic Mechanisms of Pulmonary Arterial Hypertension

  2022cites this paper
• Monocarboxylate Transporter 6-Mediated Interactions with Prostaglandin F2α: In Vitro and In Vivo Evidence Utilizing a Knockout Mouse Model

  2020cites this paper
• PGE2 vs PGF2α in human parturition.

  2020cites this paper
• Effect of IgE-stimulated alveolar macrophages on tracheal epithelial bioelectric properties in dogs

  2007cites this paper
• The biochemical properties of the pulmonary circulation

  2007cites this paper
• Measurement of endothelial metabolic functions in vivo

  2006cites this paper
• Proceedings of the British Pharmacological Society

  2004cites this paper
• [Prostanoid release and lipid peroxidation in patients with thoracic trauma].

  1999cites this paper
• Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung.

  1997cites this paper
• Oral bioavailability and first-pass effects.

  1997cites this paper
• Effect of azelastine on airway hyperresponsiveness mediated by stimulated macrophages.

  1995cites this paper
• Influence of endothelium and surgical preparation on responses of human saphenous vein and internal thoracic artery to angiotensin II.

  1994cites this paper
• Thromboxane--co-factor of pulmonary disturbances in intramedullary nailing.

  1993cites this paper
• Vasoactive intestinal peptide and helodermin inhibit the release of cyclo-oxygenase products induced by leukotriene D4 and bradykinin from guinea-pig perfused lung.

  1992cites this paper
• Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis.

  1992cites this paper
• Effect of K+ channel‐modulating drugs on the vasoconstrictor responses of leukotrienes C4, D4 and angiotensin II in the guinea‐pig isolated perfused heart

  1992cites this paper
• Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea‐pig lung parenchyma to histamine, acetylcholine and leukotriene D4

  1991cites this paper
• Stimulation of airway ciliary motility by immunologically activated canine pulmonary macrophages: role of leukotrienes.

  1991cites this paper
• The role of the epithelium in modulating the responses of guinea‐pig trachea induced by bradykinin in vitro

  1990cites this paper
• Primary pulmonary hypertension: diagnosis, medical and surgical treatment.

  1990cites this paper
• Transpulmonary prostaglandin F2α metabolism in sheep: an in vivo model

  1989cites this paper
• Transpulmonary prostaglandin F2 alpha metabolism in sheep: an in vivo model.

  1989cites this paper
• Prostanoid production by rat aortic endothelial cells by bradykinin and histamine.

  1989cites this paper
• Evaluation of endothelial injury in the human lung.

  1989cites this paper
• Sequential Patterns of Eicosanoid, Platelet, and Neutrophil Interactions in the Evolution of the Fulminant Post‐traumatic Adult Respiratory Distress Syndrome

  1989cites this paper
• The Phenomenon and Rationale of Marked Dependence of Drug Concentration on Blood Sampling Site

  1989cites this paper
• Interpretation of metabolic function of the lung. Influence of perfusion, kinetics, and injury.

  1989cites this paper
• Inhibition of leukotriene release in anaphylactic guinea‐pig hearts by a 5‐lipoxygenase inhibitor, CGS 8515

  1988cites this paper
• Beneficial Effect of Cyclooxygenase Inhibition on Adverse Hemodynamic Responses after Protamine

  1988cites this paper
• Effects of intravenous prostaglandins F2 alpha and E2 in hypoxic and non-hypoxic rabbits with elastase induced emphysema.

  1988cites this paper
• The clinical significance of prostaglandins and thromboxane as mediators of septic shock

  1987cites this paper
• Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.

  1987cites this paper
• The detection of 5-lipoxygenase and cyclo-oxygenase products in sputum of patients with chronic bronchitis and bronchiectasis.

  1987cites this paper
• von Willebrand factor abnormalities in primary pulmonary hypertension.

  1987cites this paper
• Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease.

  1987cites this paper
• Measurement of endothelial metabolic functions in vivo.

  1987cites this paper
• Pharmacological aspects of metabolic processes in the pulmonary microcirculation.

  1986cites this paper
• Release of eicosanoids from cultured rat aortic endothelial cells; studies with arachidonic acid and calcium ionophore A23187.

  1986cites this paper
• Release of eicosamoids from cultured rat aortic endothelial cells; studies with arachidonic acid and calcium ionophore A23187

  1986cites this paper
• Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet‐activating factor is mediated by leukotriene C4

  1986cites this paper
• Kinetics of the generation and action of chemical mediators in zymosan‐induced inflammation of the rabbit peritoneal cavity

  1986cites this paper
• Species variations in the pulmonary responses to arachidonic acid metabolites.

  1985cites this paper
• Lung Metabolism of Eicosanoids: Prostaglandins, Prostacyclin, Thromboxane, and Leukotrienes

  1985cites this paper
• Generation of C5a and prostacyclin (PGI2) in an inflammatory response to zymosan and a reversed passive Arthus-type reaction in the peritoneal cavity of the rabbit

  1985cites this paper
• Prostaglandin F2 alpha improves oxygen tension and reduces venous admixture during one-lung ventilation in anesthetized paralyzed dogs.

  1985cites this paper
• Species variations in the pulmonary responses to arachidonic acid metabolites.

  1985cites this paper
• Eicosanoids and the lungs.

  1984cites this paper
• Hypoxic pulmonary vasoconstriction and endogenous prostaglandin (PG) and thromboxane (TX) release in anesthetized pigs.

  1984cites this paper
• First-Pass Elimination Basic Concepts and Clinical Consequences

  1984cites this paper
• The diseased lung and drugs.

  1984cites this paper
• Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo‐oxygenase products in rat skin allografts

  1984cites this paper
• Plexogenic pulmonary hypertension of unknown origin. What's new?

  1984cites this paper
• Evaluation of antiarrhythmic activity of prostaglandin F2α in man

  1983cites this paper
• Endogenous prostaglandin F2 alpha in the hyperdynamic state of severe sepsis in man.

  1983cites this paper
• Evaluation of antiarrhythmic activity of prostaglandin F2 alpha in man.

  1983cites this paper
• [Current status of plexogenic pulmonary arteriopathy of unknown origin].

  1983cites this paper
• [A study of prostaglandin F2 alpha metabolism in experimentally induced pulmonary vascular bed diminution and oleic-acid induced lung injury in dogs].

  1983cites this paper
• Endogenous prostaglandin F2α in the hyperdynamic state of severe sepsis in man

  1983cites this paper
• [Metabolism of PGF2 alpha in pulmonary circulation and broncho-alveolar system].

  1982cites this paper
• Cognitive events and mental imagery as factors in the metabolic degradation and inactivation of prostaglandin E1 in the lungs.

  1982cites this paper
• Effects of the oestrous cycle on the metabolism of arachidonic acid in rat isolated lung.

  1982cites this paper
• Interaction of leukotrienes with cyclo-oxygenase products in guinea pig isolated trachea.

  1982cites this paper
• Metabolic fate of thromboxane A2 and prostacyclin.

  1982cites this paper
• Propranolol uptake by dog lung: effect of pulmonary artery occlusion and shock lung.

  1982cites this paper
• Impaired lung uptake of propranolol in human pulmonary emphysema.

  1982cites this paper
• Actions of leukotrienes on vascular, airway, and gastrointestinal smooth muscle.

  1982cites this paper
• The effects of aspirin and methysergide, singly and in combination, on systemic haemodynamic responses to pulmonary embolism

  1981cites this paper
• Digital clubbing and hypertrophic osteoarthropathy: The underlying mechanisms.

  1981cites this paper
• Bradykinin-stimulated prostaglandin E2 production by endothelial cells and its modulation by antiinflammatory compounds

  1981cites this paper
• Influence of the lung on arterial levels of endogenous prostaglandins E and F.

  1981cites this paper
• Hypoventilation and elevation of end-expiratory pressure release a substance which relaxes isolated arteries and disaggregates platelets in the presence of cyclooxygenase inhibitors.

  1981cites this paper
• Prostaglandins, slow-reacting substances (leukotrienes) and the lung.

  1981cites this paper
• Pharmacokinetics of prostaglandins: prediction of steady-state concentrations during intravenous infusion.

  1980cites this paper
• Metabolism of vasoactive hormones in human isolated lung.

  1980cites this paper
• Prostaglandin F-2 alpha functions as a local hormone on human airways.

  1980cites this paper
• Antagonism of Bradykinin Bronchoconstriction by Anti-Inflammatory Drugs

  1979cites this paper
• A pharmacological study of the mediators released following anaphylaxis of the sensitised hind quarters of the guinea-pig [proceedings].

  1979cites this paper
• Potential pitfalls in the conventional pharmacokinetic studies: Effects of the initial mixing of drug in blood and the pulmonary first-pass elimination

  1979cites this paper
• THE EFFECTS OF GLUCOCORTICOIDS ON THE DISTRIBUTION AND MOBILISATION OF ARACHIDONIC ACID IN FAT CELL GHOSTS

  1979cites this paper
• Haemodynamic variables during repeated exercise in chronic lung disease.

  1978cites this paper
• RELEASE OF MEDIATORS OF ANAPHYLAXIS: INHIBITION OF PROSTAGLANDIN SYNTHESIS AND THE MODIFICATION OF RELEASE OF SLOW REACTING SUBSTANCE OF ANAPHYLAXIS AND HISTAMINE

  1978cites this paper
• The role of endogenous prostaglandins in the pulmonary circulation.

  1978cites this paper
• THE RELEASE OF PROSTAGLANDINS AND THROMBOXANES FROM GUINEA‐PIG LUNG BY SLOW REACTING SUBSTANCE OF ANAPHYLAXIS, AND ITS INHIBITION

  1978cites this paper
• Prostaglandin-synthesis inhibitors in prophylaxis of food intolerance.

  1978cites this paper
• INHIBITION BY GLUCOCORTICOIDS OF PROSTAGLANDIN RELEASE FROM ADIPOSE TISSUE in vitro

  1977cites this paper